• 52,905+ CME Conference Registrations Sold
  • 158,715+ Medical Conferences
  • 285 Specialties
  • 11,456 Organizers
  • 157,299 Speakers
  • 159 Countries
  • 4,812 Cities
CME : 1.5

Integration of Immunotherapy for Non-Small Cell Lung Carcinoma: Current and Future Perspectives is organized by American Society for Radiation Oncology (ASTRO) and will be held from Feb 05, 2017 - Feb 04, 2020.

The target audience for this medical event is radiation oncologists, medical oncologists, surgeons, radiation biologists and specialists. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.

Learning Objectives
• Describe the strategies used to incorporate immunotherapeutic medications with radiation therapy in patients with LA- NSCLC.
• Describe how Investigators are attempting to incorporate immune checkpoint inhibitors with radiation therapy in patients with NSCLC.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Immunotherapies


Activity Fee : USD $105.00

Live to Virtual Conference

Market your online event to Million plus Healthcare professionals.